Literature DB >> 3177037

Fatal brain abscesses caused by Ramichloridium obovoideum: report of three cases.

E S Mahgoub, A H Chagla.   

Abstract

Three cases of brain abscesses caused by Ramichloridium obovoideum are reported. Inspite of adequate antifungal chemotherapy and multiple surgical procedures, all the three patients died of the rupture of a recurrant abscess into the ventricles. Ramichloridium obovoideum was identified as the causative fungus of these brain abscesses. Clinical, histological and mycological features of these cases are described. To our knowledge this is the first time that this fungus is isolated from a brain abscess in Saudi Arabia. The possibility that this life threatening cerebral mycosis may be endemic in this part of the world is considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177037     DOI: 10.1007/bf01402887

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  [Case of cutaneous chromoblastomycosis with fatal cerebral metastasis].

Authors:  R FUKUSHIRO; S KAGAWA; S NISHIYAMA; H TAKAHASHI
Journal:  Presse Med       Date:  1957-12-25       Impact factor: 1.228

2.  [Cerebral mycosis from Cladosporium trichoïdes in a native of the Belgian Congo].

Authors:  C LUCASSE; J CHARDOME; P MAGIS
Journal:  Ann Soc Belg Med Trop (1920)       Date:  1954-08-31

3.  Brain abscess caused by Cladosporium trichoides.

Authors:  F G Middleton; P F Jurgenson; J P Utz; S Shadomy; H J Shadomy
Journal:  Arch Intern Med       Date:  1976-04

4.  Drechslera hawaiiensis: causative agent of a fatal fungal meningo-encephalitis.

Authors:  F J Fuste; L Ajello; R Threlkeld; J E Henry
Journal:  Sabouraudia       Date:  1973-03

5.  The compromised host and infection. II. Deep fungal infection.

Authors:  P D Hart; E Russell; J S Remington
Journal:  J Infect Dis       Date:  1969-08       Impact factor: 5.226

6.  Brain abscess caused by a variety of cladosporium trichoides.

Authors:  B J Seaworth; K J Kwon-Chung; J D Hamilton; J R Perfect
Journal:  Am J Clin Pathol       Date:  1983-06       Impact factor: 2.493

7.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06

8.  Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine.

Authors:  E R Block; A E Jennings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

  8 in total
  6 in total

1.  SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").

Authors:  H M Al-Abdely; L Najvar; R Bocanegra; A Fothergill; D Loebenberg; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan.

Authors:  Alejandro Cristini; Dea Garcia-Hermoso; Marie Celard; Gilles Albrand; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

3.  Intracranial mycotic infections in neurosurgical practice.

Authors:  A B Jamjoom; S A al-Hedaithy; Z A Jamjoom; M al-Hedaithy; S F el-Watidy; N Rahman; M al-Moallem
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 4.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa.

Authors:  D A Sutton; M Slifkin; R Yakulis; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera.

Authors:  M Arzanlou; J Z Groenewald; W Gams; U Braun; H-D Shin; P W Crous
Journal:  Stud Mycol       Date:  2007       Impact factor: 16.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.